Gregory J. Tsongalis, BS, MS, PhD
Title(s)
Professor of Pathology and Laboratory Medicine
Additional Titles/Positions/Affiliations
Vice Chair for Research and
Director, Clinical Genomics and Advanced Technology (CGAT)
Department(s)
Pathology and Laboratory Medicine
Education
Univ. of Massachusetts, Amherst, BS, 1984
Quinnipiac College, MHS, 1986
Univ. of Medicine and Dentistry of New Jersey, PhD 1990
Uniiv. of North Carolina, Chapel Hill, post-doctoral 1990-1994
Programs
Norris Cotton Cancer Center
Program in Experimental and Molecular Medicine
Websites
DHMC-CGAT.com
Academic Analytics
View Profile
Contact Information
Department of Pathology and Laboratory Medicine
Dartmouth-Hitchcock Medical Center
One Medical Center Drive
Lebanon NH 03756
Office: WTRB 4th floor
Phone: 603-650-5498
Fax: 603-650-6120
Email: Gregory.J.Tsongalis@hitchcock.org
Assistant: Amber Erskine
Asst. Phone: 603-650-6821
Asst. Email: amber.j.erskine@hitchcock.org
Professional Interests
Development of advanced diagnostic technologies and disease biomarker discovery.
Grant Information
01/2014-12/30/15; Molecular profiling of tumor and ctDNA, riends of NCCC Scholar $50,000
03/01/13-01/31/2018; 1P20GM104416, Investigator / 2% COBRE Center for Molecular Epidemiology, Federal Direct Costs: $1,793,732
A rapid, multiplex digital PCR assay to detect gene variants and fusions in non-small cell lung cancer. Validation of a Droplet Digital PCR (ddPCR) Assay to Detect Cyanobacterial 16S rDNA in Human Lung Tissue. Providing Diagnostic Pathology Services in Low and Middle-Income Countries. A Novel Method to Detect Copy Number Variation in Melanoma: Droplet Digital PCR for Quantitation of the CDKN2A Gene, a Proof-of-Concept Study. Inferring spatial transcriptomics markers from whole slide images to characterize metastasis-related spatial heterogeneity of colorectal tumors: A pilot study. Validation of a rapid HLA-DQA1*05 pharmacogenomics assay to identify at-risk resistance to anti-tumor necrosis factor therapy among patients with inflammatory bowel disease. Identification of Spatial Proteomic Signatures of Colon Tumor Metastasis: A Digital Spatial Profiling Approach. Gain of CCND1 May Occur Too Infrequently in Cutaneous Melanoma, and Too Late in Melanomagenesis, to Be Diagnostically Useful: Genomic Analysis of 88 Cases. Utility of Retrospective Molecular Analysis in Diagnostically Challenging Mesenchymal Neoplasms. Molecular diagnostics and the laboratory developed test: A tale of success and the potential impacts of increased regulation. |
|